Searchable abstracts of presentations at key conferences in endocrinology

ea0047oc24 | Spotlight on Prostate Cancer | Theranostics2016

How to get away with PET+MRI

Iagaru Andrei

Stanford University has installed the first GE SIGNA PET+MRI world-wide in December 2013 as part of a comprehensive research program expanding the successful Radiological Sciences Laboratory (RSL) MRI research and the Molecular Imaging Program at Stanford (MIPS) expertise. The presentation will address the challenges, opportunities and success stories of the program after 3 years of research activities....

ea0089c25 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging | NANETS2022

Evaluation of 68Ga-DOTATATE PET After Two Cycles of Peptide Receptor Radionuclide Therapy (PRRT) in Neuroendocrine Tumors (NET)

Heying Duan , Hong Song , Valentina Ferri , George Fisher , Shagufta Shaheen , Jagruti Sha , Judy Nguyen , Farshad Moradi , Ben Franc , Guido Davidzon , Andrei Iagaru , Aparici Carina Mari

Background: We aimed to evaluate the added information provided by 68Ga-DOTATATE PET after two cycles of peptide receptor radionuclide therapy (PRRT) in patients with somatostatin receptor (SSTR)-expressing neuroendocrine tumors (NET).Methods: In this retrospective study, 105 patients (54 women and 51 men, 62.5&pm;10.5-year-old) with progressive NET treated with at least two cycles of 177Lu-DOTATATE were included. All patients had <...